ALR Insider Trading
ALR | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at ALR provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2023-03-20 16:24 | 2023-03-18 | PORTNOY ADAM D. | Director | BUY | $1.31 | 22,375,687 | $29,312,150 | 22,375,687 | +100.0% |
| 2022-03-04 00:01 | 2022-03-01 | Cody Lauren C. | Officer - EVP & CCO | BUY | $2.52 | 40,000 | $100,800 | 40,000 | +100.0% |
| 2016-04-28 00:21 | 2015-01-16 | Flakne Carla | Officer - VP, Chief Accounting Officer | SELL | $42.45 | 10,000 | $424,450 | 3,714 | -72.9% |
| 2016-04-12 22:07 | 2015-01-13 | GOLDBERG CAROL R | Director | SELL | $39.46 | 110 | $4,341 | 40,024 | -0.3% |
| 2016-02-04 01:24 | 2016-02-01 | Guerdan Melissa | Officer - SVP, Global Quality & Reg. | OPT+S | $54.00 | 2,500 | $135,000 | 0 | 0.0% |
| 2015-11-16 17:30 | 2015-11-13 | Hargadon Robert Bernard | Officer - SVP, Global Human Resources | BUY | $38.99 | 1,000 | $38,990 | 8,843 | +12.8% |
| 2015-11-12 21:49 | 2015-11-12 | Hinrichs James F. | Officer - Executive VP, CFO | BUY | $39.97 | 10,000 | $399,700 | 30,000 | +50.0% |
| 2015-09-04 23:01 | 2015-09-03 | Guerdan Melissa | Officer - SVP, Global Quality & Reg. | SELL | $52.00 | 5,135 | $267,020 | 0 | -100.0% |
| 2015-09-04 23:01 | 2015-09-03 | Gladwell Mark | Officer - Senior VP, Global Operations | SELL | $52.27 | 2,651 | $138,555 | 0 | -100.0% |
| 2015-09-02 23:52 | 2015-08-31 | Gladwell Mark | Officer - Senior VP, Global Operations | OPT+S | $52.23 | 27,513 | $1,437,059 | 2,651 | 0.0% |
| 2015-09-02 23:51 | 2015-09-01 | Guerdan Melissa | Officer - SVP, Global Quality & Reg. | OPT+S | $50.48 | 5,000 | $252,413 | 5,135 | 0.0% |
| 2015-08-18 23:50 | 2015-08-14 | Malkani Sanjay | Officer - Global Pres., Toxicology | OPT+S | $54.60 | 31,460 | $1,717,716 | 6,222 | 0.0% |
| 2015-08-10 21:16 | 2015-08-07 | Hinrichs James F. | Officer - Executive VP, CFO | BUY | $49.33 | 20,000 | $986,570 | 20,000 | +100.0% |
| 2015-06-11 00:03 | 2015-06-08 | Malkani Sanjay | Officer - Global Pres., Toxicology | OPT+S | $50.87 | 24,331 | $1,237,645 | 6,222 | 0.0% |
| 2015-06-08 23:48 | 2015-06-04 | Malkani Sanjay | Officer - Global Pres., Toxicology | OPT+S | $52.18 | 15,669 | $817,640 | 6,222 | 0.0% |
| 2015-06-03 00:07 | 2015-06-01 | BRIDGEN JOHN | Officer - Sr VP, Business Develop | OPT+S | $51.19 | 7,500 | $383,933 | 4,552 | 0.0% |
| 2015-06-03 00:07 | 2015-05-29 | BRIDGEN JOHN | Officer - Sr VP, Business Develop | OPT+S | $51.17 | 22,564 | $1,154,487 | 4,552 | 0.0% |
| 2015-05-16 00:06 | 2015-01-13 | GOLDBERG CAROL R | Director | SELL | $39.46 | 110 | $4,341 | 0 | -100.0% |
| 2015-05-04 23:58 | 2015-04-30 | Guerdan Melissa | Officer - SVP, Global Quality & Reg. | OPT+S | $47.81 | 3,031 | $144,912 | 0 | 0.0% |
| 2015-04-16 16:53 | 2015-03-16 | Flakne Carla | Officer - VP, Chief Accounting Officer | OPT+S | $48.99 | 8,500 | $416,449 | 3,252 | 0.0% |
| 2015-04-09 02:53 | 2015-04-06 | Guerdan Melissa | Officer - SVP, Global Quality & Reg. | OPT+S | $50.00 | 2,500 | $125,000 | 0 | 0.0% |
| 2015-03-25 23:38 | 2015-03-23 | Guerdan Melissa | Officer - SVP, Global Quality & Reg. | OPT+S | $48.35 | 13,476 | $651,497 | 0 | 0.0% |
| 2015-03-19 23:35 | 2015-03-17 | BRIDGEN JOHN | Officer - Sr VP, Business Develop | OPT+S | $48.53 | 25,000 | $1,213,250 | 4,552 | 0.0% |
| 2015-03-19 01:20 | 2015-03-16 | Flakne Carla | Officer - VP, Chief Accounting Officer | OPT+S | $48.99 | 8,500 | $416,449 | 0 | 0.0% |
| 2015-02-26 00:54 | 2015-02-23 | Gladwell Mark | Officer - Senior VP, Global Operations | OPT+S | $44.62 | 13,292 | $593,036 | 0 | 0.0% |
| 2015-01-21 00:10 | 2015-01-16 | Flakne Carla | Officer - VP, Chief Accounting Officer | OPT+S | $42.45 | 10,000 | $424,450 | 3,252 | 0.0% |
| 2014-12-12 21:12 | 2014-12-11 | BRIDGEN JOHN | Officer - Sr VP, Business Develop | OPT+S | $37.07 | 50,000 | $1,853,400 | 4,552 | 0.0% |
| 2014-08-18 23:09 | 2014-08-15 | Teitel Dave | Officer - Chief Financial Officer | OPT+S | $35.07 | 10,000 | $350,700 | 5,002 | 0.0% |
| 2013-12-14 00:55 | 2013-12-11 | Torchilin Kate | Officer - VP, Connected Health | OPT+S | $33.73 | 8,547 | $288,265 | 2,128 | 0.0% |
| 2013-11-15 05:37 | 2013-11-12 | HEMPEL PAUL T | Officer - SVP Ethics & Compliance | OPT+S | $33.74 | 4,576 | $154,372 | 19,862 | 0.0% |
| 2013-08-17 00:36 | 2013-08-15 | Teitel Dave | Officer - Chief Financial Officer | OPT+S | $31.73 | 10,000 | $317,282 | 4,506 | 0.0% |
| 2013-08-08 01:49 | 2013-08-05 | Cotton Michael Lester | Officer - Global Pres, Health Mgmt | OPT+S | $33.82 | 12,500 | $422,750 | 0 | 0.0% |
| 2013-06-04 21:37 | 2013-05-31 | Cotton Michael Lester | Officer - Global Pres, Health Mgmt | OPT+S | $25.86 | 8,750 | $226,240 | 0 | 0.0% |
| 2013-03-12 03:19 | 2013-03-07 | Post Jim | Officer - President, Acute Care | SELL | $23.37 | 1,075 | $25,123 | 0 | -100.0% |
| 2013-03-07 20:06 | 2013-03-05 | QUELCH JOHN | Director | OPT+S | $23.49 | 20,220 | $475,065 | 9,780 | 0.0% |
| 2013-03-05 18:03 | 2013-03-01 | EYLENBOSCH HILDE | Officer - President, Alere International | OPT+S | $22.69 | 2,391 | $54,245 | 30,245 | 0.0% |
| 2012-08-27 23:24 | 2012-08-23 | Post Jim | Officer - President, Alere NA | SELL | $18.77 | 840 | $15,767 | 502 | -62.6% |
| 2012-08-16 22:30 | 2012-08-14 | TOOHEY DAVID | Officer - President, Intl Bus. Operation | OPT+S | $18.28 | 151 | $2,760 | 9,087 | 0.0% |
| 2012-08-09 23:50 | 2012-08-07 | BRIDGEN JOHN | Officer - Sr VP, Business Develop | OPT+S | $18.96 | 11,721 | $222,218 | 2,633 | 0.0% |
| 2012-07-23 22:25 | 2012-07-19 | BRIDGEN JOHN | Officer - VP, Strategic Business Develop | OPT+S | $20.00 | 4,752 | $95,040 | 2,633 | 0.0% |
| 2012-06-15 22:28 | 2012-06-13 | HEMPEL PAUL T | Officer - SVP Ethics & Compliance | OPT+S | $19.01 | 10,113 | $192,201 | 18,485 | 0.0% |
| 2012-04-30 22:19 | 2010-04-26 | BRIDGEN JOHN | Officer - VP, Strategic Business Develop | OPT+S | $25.00 | 3,486 | $87,150 | 2,633 | 0.0% |
| 2012-03-09 19:45 | 2012-03-07 | BRIDGEN JOHN | Officer - VP, Strategic Business Develop | OPT+S | $25.00 | 4,357 | $108,925 | 2,633 | 0.0% |
| 2012-02-22 00:56 | 2012-02-16 | Underwood Thomas | Officer - CEO, Alere Health LLC | OPT+S | $26.02 | 750 | $19,516 | 1,500 | 0.0% |
| 2012-02-09 23:02 | 2012-02-07 | BRIDGEN JOHN | Officer - VP, Strategic Business Develop | OPT+S | $25.10 | 5,446 | $136,695 | 2,633 | 0.0% |
| 2012-02-07 00:36 | 2012-02-02 | BRIDGEN JOHN | Officer - VP, Strategic Business Develop | OPT+S | $25.00 | 6,808 | $170,200 | 2,633 | 0.0% |
| 2011-12-01 04:02 | 2011-11-28 | MCALEER JEROME F | Director, Officer - VP, Research & Development | OPT+S | $22.25 | 116,829 | $2,599,212 | 297,270 | 0.0% |
| 2011-11-19 00:23 | 2011-11-16 | SCOTT DAVID | Director, Officer - Chief Technical Officer | OPT+S | $26.02 | 164,237 | $4,273,775 | 475,669 | 0.0% |
| 2011-11-18 00:29 | 2011-11-15 | EYLENBOSCH HILDE | Officer - Chief Commercial Officer | OPT+S | $26.02 | 17,229 | $448,367 | 30,136 | 0.0% |
| 2011-08-25 04:08 | 2011-08-23 | Roosevelt James Jr. | Director | BUY | $22.50 | 4,444 | $99,990 | 4,444 | +100.0% |
How to Interpret $ALR Trades
Not every insider transaction in ALR is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ALR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ALR
Insider activity data for ALR is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ALR, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.